Capital World Investors’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-250,000
Closed -$525K 518
2022
Q4
$525K Hold
250,000
﹤0.01% 529
2022
Q3
$573K Hold
250,000
﹤0.01% 537
2022
Q2
$708K Sell
250,000
-371,065
-60% -$1.31M ﹤0.01% 550
2022
Q1
$2.82M Sell
621,065
-253,935
-29% -$1.4M ﹤0.01% 545
2021
Q4
$7.11M Hold
875,000
﹤0.01% 563
2021
Q3
$11M Hold
875,000
﹤0.01% 556
2021
Q2
$13.5M Hold
875,000
﹤0.01% 551
2021
Q1
$17.7M Hold
875,000
﹤0.01% 522
2020
Q4
$23.7M Hold
875,000
﹤0.01% 485
2020
Q3
$16.2M Hold
875,000
﹤0.01% 482
2020
Q2
$15.6M Hold
875,000
﹤0.01% 455
2020
Q1
$8.05M Hold
875,000
﹤0.01% 452
2019
Q4
$15M Hold
875,000
﹤0.01% 444
2019
Q3
$9.1M Hold
875,000
﹤0.01% 474
2019
Q2
$13.7M Hold
875,000
﹤0.01% 468
2019
Q1
$16M Hold
875,000
﹤0.01% 458
2018
Q4
$14.6M Hold
875,000
﹤0.01% 454
2018
Q3
$24.7M Hold
875,000
0.01% 452
2018
Q2
$24.8M Buy
+875,000
New +$26.1M 0.01% 444

Other funds holding CLLS

Capital World Investors's CLLS Position: Q1 2023 in Review

Capital World Investors sold out of Cellectis (CLLS) in Q1 2023, closing a stake of 250,000 shares — an estimated $525K sold.

Capital World Investors first reported a position in CLLS in Q2 2018 and held it in 19 quarters. The position peaked at $24.8M in Q2 2018. 33 funds tracked by Wall St. Rank hold CLLS as of Q1 2023.

  • Capital World Investors reported no remaining Cellectis position as of Q1 2023 after selling out during the quarter.
  • Capital World Investors sold 250,000 Cellectis shares in Q1 2023, an estimated $525K.
  • Capital World Investors first reported a position in Cellectis in Q2 2018 and held it in 19 quarters.
  • Capital World Investors's Cellectis position peaked at $24.8M in Q2 2018.
  • 33 funds tracked by Wall St. Rank held Cellectis as of Q1 2023.

Based on Capital World Investors's 13F filing for Q1 2023, filed 15 May 2023.